ISO 13485 Is Now the Law of the US Operating Room

The FDA's new quality framework replaces a 30-year-old inspection model, raising the compliance bar for every surgical device on the market

7 May 2026

A landmark compliance shift is rewriting the rules for every medical device that enters a US operating room. On February 2, 2026, the FDA activated its Quality Management System Regulation, retiring manufacturing standards that had governed the sector for nearly three decades. The new framework aligns with ISO 13485:2016, the global benchmark for medical device quality management.

Gone is the FDA's Quality System Inspection Technique, the four-subsystem model embedded in regulatory audits since the late 1990s. Its replacement, Compliance Program 7382.850, takes a risk-based approach that traces quality decisions across a product's entire lifecycle. Inspectors now have access to records previously off-limits, including internal management reviews and supplier audit documentation, to judge whether a manufacturer's quality system works as a cohesive whole.

The compliance bar has risen sharply for surgical device suppliers. Robotic instruments, sterilization equipment, imaging systems, and OR monitoring devices all fall under heightened scrutiny. Reopened corrective actions and repeat nonconformances now serve as primary signals of systemic failure.

On April 1, 2026, the FDA convened an industry town hall to clarify what the updated inspection model actually requires. Smaller manufacturers have been vocal about the burden of rebuilding compliance programs designed entirely around the retired QSIT framework. The shift demands documented, risk-based decision-making at every stage of a device's life, which is no small ask for companies that haven't had to think that way before.

Hospital procurement teams are feeling the pressure too. Confirming QMSR compliance is now embedded in supplier verification for every OR purchasing decision, adding new due diligence responsibilities to an already complex process.

For companies that move quickly, the upside is real. ISO 13485 alignment opens a path to streamlined compliance across Europe, Canada, and Japan, reducing the duplicative regulatory legwork that has long frustrated global suppliers. The updated framework signals a US surgical supply chain where quality accountability follows a device from design bench to operating table, and where cutting corners carries consequences that are harder to obscure.